Aveanna Healthcare Holdings Inc.

What they do

Aveanna delivers home healthcare services through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS includes private duty nursing and pediatric therapy, primarily for children. HHH provides home health and hospice care. MS supplies durable medical equipment and related products.

Revenue drivers

• Private Duty Services (PDS) — Largest segment, generating $553.9 million in Q2 2026 (83% of consolidated revenue), up from $486.0 million a year ago. Growth from private duty nursing and pediatric therapy services.
• Home Health & Hospice (HHH) — Second segment, $69.0 million in Q2 2026 (10% of revenue), up from $60.1 million, reflecting 14.8% year-over-year growth.
• Medical Solutions (MS) — Smallest segment, $47.5 million in Q2 2026 (7% of revenue), up from $43.4 million, a 9.4% increase.

Recent performance

In Q2 2026, revenue increased 13.7% to $670.5 million, with net income of $40.3 million (6.0% of revenue) compared to $27.0 million in Q2 2025. Adjusted EBITDA rose 8.0% to $95.4 million (14.2% of revenue). For the first half of 2026, revenue grew 14.8% to $1.32 billion, and net income was $81.9 million. The balance sheet at July 4, 2026 showed $97.2 million cash, $1.28 billion long-term debt, and total assets of $2.11 billion.

Strategy

Management emphasizes organic growth across all three segments, citing the success of its 'Preferred Payor and Government Affairs' strategies. The company has invested in clinical programs and technology-enabled systems to support care delivery. It aims to maintain relationships with referral sources and manage payer mix, including Medicare Advantage and managed care. The 8-K highlights raising full-year guidance, reflecting confidence in continued momentum.

Risks

• Reimbursement rate pressure — Aveanna has limited control over rates from Medicare, Medicaid, and private insurers; changes could negatively impact revenue and margins.
• Payer concentration and changes — Dependence on third-party payers, including Medicare and Medicaid, and shifts toward managed care could reduce reimbursement levels.
• Intense competition — The home health, hospice, and durable medical equipment markets are highly competitive, which could affect patient volumes and pricing.
• Billing and collection delays — Transitioning between clinical data and billing systems can lead to delays or non-collection of patient accounts receivable, impacting cash flow.

Outlook

Management raised full-year 2026 revenue guidance to greater than $2.68 billion (from $2.63-$2.65 billion) and Adjusted EBITDA to greater than $365 million (from $338-$342 million). The company cites strong first-half performance and confidence in continued organic growth across all segments. The next quarterly report would be for the period ending October 3, 2026.